The UGIRA International Registry for RAMIG for Gastric Cancer

Recruiting Observational Study
Gastric Cancer (Diagnosis) Gastrectomy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Chinese University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Minimally invasive gastrectomy (MIG) has gained in popularity, since it is feasible, safe and oncologically comparable to open gastrectomy, while morbidity and duration of hospitalization are reduced, quality of life is increased, and conversion rate is low. However, several challenges are faced during MIG, such as impaired depth perception and limited range of motion of instrument tips. Robot-As…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All gastric cancer patients undergoing RAMIG in a center Exclusion Criteria: * No
Contacts

Shannon Melissa CHAN, MBChB, FRCSEd, FHKAM (Surgery)

+852 3505 2956

shannonchan@surgery.cuhk.edu.hk

CONTACT